Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares U.S. Pharmaceutical ETF (NY:IHE)

90.48 +0.06 (+0.07%)
Streaming Delayed Price Updated: 3:35 PM EST, Feb 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iShares U.S. Pharmaceutical ETF

< Previous 1 2 3 Next >
News headline image
J&J ETFs to Gain on Upbeat COVID-19 Vaccine Data ↗
Johnson & Johnson has again announced positive data highlighting the efficiency of its single-shot COVID-19 vaccine in providing protection against COVID-related hospitalizations. 
Via Talk Markets
News headline image
Will Pfizer ETFs Soar on FDA's COVID-19 Vaccine Booster Approval? ↗
Investors have one more reason to cheer the COVID-19 vaccine update as the FDA has approved emergency use of a booster dose of the Pfizer Inc. and BioNTech SE COVID-19 vaccine. 
Via Talk Markets
News headline image
3 Dividend-Paying Pharmaceutical Stocks to Buy This Summer ↗
The pharmaceutical industry has benefited from much investor attention amid the COVID-19 pandemic. 
Via Talk Markets
News headline image
Tuesday Talk: Slip Sliding Sideways ↗
With the Middle East seemingly going to Hell in a proverbial handbasket the markets seem to be slip sliding, not away (as the Paul Simon song would have it) sideways as it were. 
Via Talk Markets
News headline image
5 Sector ETFs That Survived Last Week's Turmoil ↗
Here are five sector ETFs that performed well last week and survived the broad market rout. 
Via Talk Markets
News headline image
Pharma ETFs in Focus Post Q1 Earnings ↗
The slew of Q1 results has led to mixed trading in pharma ETFs over the past month. Here are those in detail. 
Via Talk Markets
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.